Biography

Scott Morrison joined our Board in 2021 and serves as Chair of the Audit Committee.

Mr. Morrison brings to our Board financial expertise obtained from his extensive business, accounting, and financial background from over 40 years of experience serving public and private companies in the life sciences industry as well as his significant experience serving on boards and audit committees of other public companies.

Mr. Morrison has served public and private companies in the life sciences industry since 1980. He was a Partner with Ernst & Young LLP from 1996 until his retirement in 2015, serving as its U.S. Life Sciences Leader from 2002. During his tenure at E&Y, he worked on hundreds of public company audits, public and private financings, M&A transactions, and corporate collaborations. Since retiring, in addition to serving on and chairing the Audit Committee of our Board, Mr. Morrison serves on public company boards, including as chair of the audit committee, for Corvus Pharmaceuticals (Nasdaq), IDEAYA Biosciences (Nasdaq), Tarsus Pharmaceuticals (Nasdaq), and Vera Therapeutics (Nasdaq). He previously served on other public company boards, including as chair of the audit committee, for Global Blood Therapeutics (Nasdaq) until its acquisition by Pfizer and Audentes Therapeutics (Nasdaq) until its sale to Astellas.

Mr. Morrison has also served as a director on several life sciences industry boards, including the Biotechnology Innovation Organization (“BIO”) Emerging Companies Section, the Bay Area Biosciences Board (now California Life Sciences or CLS), the Life Sciences Foundation, and the Biotechnology Institute. Mr. Morrison was awarded the CLS Pantheon 2016 Life Sciences Leadership Award.

Mr. Morrison received a B.S. in Business Administration from the Haas School at University of California, Berkeley and is a Certified Public Accountant (inactive).